India, Oct. 13 -- The Institute of Liver and Biliary Sciences (ILBS) in Delhi has tested more than 30,000 blood donor samples using Individual Donor Nucleic Acid Testing (NAT) since introducing the technology in January 2024, according to the institute.

ILBS said it is currently the only Delhi government hospital conducting Individual Donor-NAT testing. The facility uses molecular screening to detect infections that can be transmitted through blood transfusions, adding a layer of screening to help improve the safety of donated blood and blood components.

NAT detects the genetic material of viruses, including HIV-1, HIV-2, hepatitis B and hepatitis C. Unlike conventional serological tests, which detect antibodies or antigens, molecular t...